Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient
We report a case of metastatic castration-resistant prostate cancer, who received prior treatment with docetaxel and was then given cabazitaxel as salvage therapy. The patient was monitored by prostate-specific antigen doubling time and prostate-specific antigen absolute value. The prostate-specific...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Editorial Department of Journal of Biomedical Research
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585438/ |